Brain-like software upgrade helps insulin pumps outsmart diabetes

NCT ID NCT05610111

Completed Disease control Sponsor: Sue Brown Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests a software upgrade for an automated insulin pump system (Control-IQ) in adults with type 1 diabetes. The upgrade adds an adaptive biobehavioral control module that learns from the user's patterns to improve blood sugar management. Participants use the standard system for a few weeks and then the upgraded version for 16 weeks, and researchers compare how much time blood sugar stays in the healthy range.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Closed-loop insulin pump system with adaptive biobehavioral control software
What this could lead to: If successful, this software upgrade could help people with type 1 diabetes spend more time in their target blood sugar range and reduce dangerous highs and lows.
What could go wrong: This is a relatively small crossover trial testing a software modification, not a new drug or cure. The improvement may be modest, and results may not apply to all insulin pump users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES

Contacts and locations

Show contact details

Locations

University of Virginia Center for Diabetes Technology

Charlottesville, Virginia, 22903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.